insights_auto
Why is PEB up १५.७९%?
Dive Deeperchevron_right
PEB:ASX
Pacific Edge Ltd
A$ ०.२२
arrow_upward
+१५.७९%(+०.०३०) 1D
नोभेम्बर ६, १६:१०:२८ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Open
A$ ०.२२
High
A$ ०.२४
Low
A$ ०.२२
Mkt. cap
३१.२० करोड
Avg. vol.
११.७७ हजार
Volume
०.००
52-wk high
A$ ०.२६
52-wk low
A$ ०.१२
No. of employees
११४
Open
A$ ०.२२
High
A$ ०.२४
Low
A$ ०.२२
Mkt. cap
३१.२० करोड
Avg. vol.
११.७७ हजार
Volume
०.००
52-wk high
A$ ०.२६
52-wk low
A$ ०.१२
No. of employees
११४
News stories
From web sources and news partners
RNZ
·
२ दिन पहिले
Shares in cancer diagnostics company Pacific Edge rise after Medicare coverage of tests
Stocks Down Under
·
२ दिन पहिले
Pacific Edge (ASX:PEB) Medicare Just Picked Its Tests. Can Revenue Finally Follow?
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd